TEM & SHV genes in extended spectrum β-lactamase producing Klebsiella species & their antimicrobial resistance pattern

Indian Journal of Medical Research

Volumn 128, Issue 6, 2008, Pages 759-764

  Jain, Amita ^a   Mondal, Rajesh ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

ESBL; Klebsiella spp.; Neonatal septicaemia; SHV; TEM

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFIXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CHLOROPHENOL; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; INDIA; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NONHUMAN; POLYMERASE CHAIN REACTION; TERTIARY HEALTH CARE;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; HUMANS; ISOELECTRIC FOCUSING; KLEBSIELLA;

EID: 61849108693     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Wu TL, Chia JH, Su LH, Kuo AJ, Chu C, Chiu CH. Dissemination of extended spectrum beta-lactamase producing Enterobacteriacae in Pediatric Intensive Care Units. J Clin Microbiol 2003; 41: 4636-8.
2. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended spectrum beta-lactamase producing Gram-negative bacteria in septicemic neonates in a tertiary care hospital. J Med Microbiol 2003; 52: 421-5.
3. Paterson DL, Ko WC, Gottberg V, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organism producing extended spectrum beta-lactamasees: Implications for clinical microbiology laboratory. J Clin Microbiol 2001; 39: 2206-12.
4. Medeiros AA. Beta-lactamases. Br Med Bull R 1984; 40: 18-27.
5. Available from: http.www.lahey.org/studies/webt.htm, accessed on February 21, 2006.
6. Livermore DM. β-lactamase in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
7. Sturenburg E, Mack D. Extended spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47: 273-95.
8. Tankhiwale SS, Jalgaonkar VS, Ahamad S, Hassani U. Extended spectrum beta-lactamase in urinary isolates. Indian J Med Res 2004; 120: 553-6.
9. Shubha S, Ananthan S. Extended spectrum beta-lactamase (ESBL)mediated resistance to third genretion cephalosporins among Klebsiealla pneumoniae in Chennai. Indian J Med Microbiol 2002; 20: 92-5.
10. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM and SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 2007; 125: 173-8.
11. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Win WC, editors. The Enterobacteriacae. In: Color atlas & textbook of diagnostic microbiology, 5th ed. Philadelphia: JB Lippincott Co; 1997. p. 171-230.
12. Bauer AW, Kirby WMM, Sherris JC, Tuck M. Antibiotics susceptibility testing by standardized single disc method. Am J Clin Pathol 1966; 45: 493-6.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th Informational Supplement; Wayne, Pennsylvania. Clinical and Laboratory Standards Institute Document M100-S16; 2006.
14. Jain A, Mondal R. Prevalence and antimicrobial resistant pattern of extended spectrum βB-lactamase producing Klebsiella spp. isolated from cases of neonatal septisaemia. Indian J Med Res 2007; 125: 89-94.
15. M' Zali FH, Chanawong A, Kerr KG, Birkenead D, Hawkey PM. Detection of extended spectrum beta-lactamases in members of the family Enterobacteriacae: comparison of the MAST DD test, the double disc and the E test ESBL. J Antimicrob Chemother 2000; 45: 881-5.
16. Mathew M, Harris AM. Identification of beta-lactamases by analytical isoelectric focussing: correlation with bacterial taxonomy. J Gen Microbiol 1976; 94: 55-67.
17. Jain A, Tiwari V, Guleria RS, Verma RK. Quantitative evaluation of mycobacterial DNA extraction protocol for polymerase chain reaction assay. Mol Biol Today 2002; 3: 43-9.
18. Mabilat C, Goussard S. PCR detection and identification of genes for extended spectrum beta-lactamase. In: Persing DH, Smith TF, Tenover FC, White TJ, editors. Diagnostic molecular microbiology: principles and applications. Washington DC: American Society for Microbiology; 1993. p. 553-63.
19. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crelin J, et al. Evolution of extended spectrum beta-lactam resistance (SHV-8) in a strain of E. coli during multiple episodes of bacteremia. Antimicrob Agent Chemother 1997; 41: 647-53.
20. Patricia A, Bradford PA. Extended spectrum beta-lactamases in 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
21. Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush KA. Multiple resistant K. pneumoniae strains from two children hospitals: identification of the extended spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrob Agents Chemther 1994; 38: 761-6.
22. Barroso H, Viera HA, Lito LM, Cristino JM, Salgado MJ, Neto HF. Survey of K. pneumonia producing extended spectrum beta- lactamase at a Portuguese hospital: TEM -10 as the endemic enzyme. J Antimicrob Chemother 2000; 45: 611-6.
23. Nordmann P. Trends in beta-lactamase resistance among enterobacteriace. Clin Infect Dis 1998; 27: 100-6.
24. Kim J, Kwon H, Pai J, Kim W, Cho DT. Survey of K. pneumoniae strains producing extended spectrum beta-lactamase: prevalence of SHV-12 and SHV-2 in Korea. J Clin Microbiol 1998; 36: 1446-9.
25. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta-lactamase producing Gram-negative bacteria in a tertiary care hospital. Indian J Med Res 2005; 122: 305-8.
26. Hansotia JB, Agarwal V, Pathak AA, Saoji AM. Extended spectrum beta-lactamase mediate resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105: 160-5.
27. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cephotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-7.